• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶的活性中心和赖氨酸结合位点在纤溶酶诱导的血小板活化和解聚中的作用。

Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation.

作者信息

Lu H, Soria C, Li H, Soria J, Lijnen H R, Perrot J Y, Caen J P

机构信息

INSERM U 150, Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France.

出版信息

Thromb Haemost. 1991 Jan 23;65(1):67-72.

PMID:1827215
Abstract

Previous studies have shown that plasmin can activate platelets and can also disperse platelet aggregates by degradation of fibrinogen bound to platelets. In this study, the role of the active center and the lysine binding sites (LBS) of human plasmin in activating platelets and in dispersing platelet aggregates is investigated using aprotinin and the tripeptide Val-Phe-Lys-CH2Cl to inhibit the active center and using epsilon-aminocaproic acid (EACA) to specifically block the LBS. Our results show that the catalytic activity of plasmin is indispensable both for activating platelets and for dispersing platelet aggregates. Binding of plasmin to platelets through the LBS enhances its activating potential, since both EACA (1 mM) and Lys-plasminogen (molar ratio of plasminogen:plasmin at 2:1 to 4:1) inhibit plasmin-induced platelet activation, whereas Glu-plasminogen at a molar ratio of 15:1 had no effect. Furthermore, plasmin which lacks the LBS (miniplasmin), is about 3 fold less effective in activating platelets. However, plasmin binding through the LBS is not absolutely required to disperse platelet aggregates, since EACA at 30 mmol/l was unable to prevent disaggregation by plasmin (half disaggregation time: 40 min in the presence of EACA against 27 min in its absence). It also appeared that fibrinogen receptors on activated platelets are resistant to plasmin degradation, and that disaggregation of plasmin-induced platelet aggregates was much slower than the degradation of fibrinogen by plasmin.

摘要

先前的研究表明,纤溶酶可激活血小板,还可通过降解与血小板结合的纤维蛋白原使血小板聚集体分散。在本研究中,使用抑肽酶和三肽缬氨酸-苯丙氨酸-赖氨酸-二氯甲烷抑制人纤溶酶的活性中心,并使用ε-氨基己酸(EACA)特异性阻断赖氨酸结合位点(LBS),研究人纤溶酶的活性中心和LBS在激活血小板及使血小板聚集体分散中的作用。我们的结果表明,纤溶酶的催化活性对于激活血小板和使血小板聚集体分散均不可或缺。纤溶酶通过LBS与血小板的结合增强了其激活潜能,因为EACA(1 mM)和赖氨酸纤溶酶原(纤溶酶原与纤溶酶的摩尔比为2:1至4:1)均可抑制纤溶酶诱导的血小板激活,而摩尔比为15:1的谷氨酸纤溶酶原则无此作用。此外,缺乏LBS的纤溶酶(微型纤溶酶)激活血小板的效力约低3倍。然而,通过LBS的纤溶酶结合对于使血小板聚集体分散并非绝对必需,因为30 mmol/l的EACA无法阻止纤溶酶引起的解聚(半数解聚时间:存在EACA时为40分钟,不存在时为27分钟)。还发现激活的血小板上的纤维蛋白原受体对纤溶酶降解具有抗性,且纤溶酶诱导的血小板聚集体的解聚比纤溶酶对纤维蛋白原的降解要慢得多。

相似文献

1
Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation.纤溶酶的活性中心和赖氨酸结合位点在纤溶酶诱导的血小板活化和解聚中的作用。
Thromb Haemost. 1991 Jan 23;65(1):67-72.
2
Characterization of plasmin-induced platelet aggregation.纤溶酶诱导的血小板聚集的特性
Res Commun Mol Pathol Pharmacol. 1997 Jun;96(3):341-52.
3
The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.载脂蛋白(a)与纤溶酶原在溶液阶段的相互作用会抑制纤溶酶原与纤溶酶修饰的纤维蛋白原表面的结合。
Biochemistry. 1997 Aug 26;36(34):10353-63. doi: 10.1021/bi962433d.
4
Plasminogen interaction with platelets: the importance of carboxyterminal lysines.纤溶酶原与血小板的相互作用:羧基末端赖氨酸的重要性。
Thromb Res. 2005;116(6):499-507. doi: 10.1016/j.thromres.2005.03.021.
5
Exposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptors.人血小板暴露于纤溶酶会导致不可逆活性纤维蛋白原受体的表达。
Thromb Haemost. 1995 Apr;73(4):693-701.
6
Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.重组载脂蛋白(a)与人血小板的结合及其对血小板聚集的影响。
Thromb Haemost. 2001 Apr;85(4):686-93.
7
Platelets and plasminogen activation.血小板与纤溶酶原激活。
Thromb Haemost. 1995 Jul;74(1):291-3.
8
Plasmin generation induces neutrophil aggregation: dependence on the catalytic and lysine binding sites.纤溶酶的生成诱导中性粒细胞聚集:对催化位点和赖氨酸结合位点的依赖性。
J Cell Physiol. 1992 May;151(2):255-61. doi: 10.1002/jcp.1041510206.
9
Role of the kringle domain in plasminogen activation with staphylokinase.kringle结构域在葡萄球菌激酶激活纤溶酶原中的作用。
J Biochem. 1998 Jan;123(1):71-7. doi: 10.1093/oxfordjournals.jbchem.a021918.
10
Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.用纤溶酶对人血小板进行预处理可抑制对凝血酶的反应,但会增强对低浓度聚集剂(包括凝血酶受体激活肽SFLLRN)的反应。
Thromb Haemost. 1997 Apr;77(4):741-7.

引用本文的文献

1
Comparison of Tranexamic Acid Administration Methods in Rhytidectomy: A Prospective, Randomized, Double-blind Study.氨甲环酸在除皱术中给药方法的比较:一项前瞻性、随机、双盲研究。
Plast Reconstr Surg Glob Open. 2025 Mar 3;13(3):e6559. doi: 10.1097/GOX.0000000000006559. eCollection 2025 Mar.
2
Safety and Efficacy of Local Tranexamic Acid for the Prevention of Surgical Bleeding in Soft-Tissue Surgery: A Review of the Literature and Recommendations for Plastic Surgery.局部氨甲环酸预防软组织手术中手术出血的安全性和有效性:文献综述及整形外科学建议。
Plast Reconstr Surg. 2022 Mar 1;149(3):774-787. doi: 10.1097/PRS.0000000000008884.
3
The ratio of concentrations of aminocaproic acid and tranexamic acid that prevent plasmin activation of platelets does not provide equivalent inhibition of plasmatic fibrinolysis.
氨甲环酸和氨甲苯酸的浓度比例可以防止纤溶酶原激活血小板,但并不能提供等效的血浆纤维蛋白溶解抑制作用。
J Thromb Thrombolysis. 2018 Oct;46(3):365-370. doi: 10.1007/s11239-018-1705-3.
4
Cleavage of the thrombin receptor: identification of potential activators and inactivators.凝血酶受体的裂解:潜在激活剂和失活剂的鉴定。
Biochem J. 1996 Nov 15;320 ( Pt 1)(Pt 1):335-41. doi: 10.1042/bj3200335.